ResearcherYangzhou UniversityNo recent work listed
Zhilin Zhang
Matched on ORCID iD 0000-0002-8605-9681; OpenAlex author ID A5100723122. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2021: 1 paper · 2022: 2 papers · 2023: 2 papers
Papers 5
- Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.216031↗
- Evaluation of Tumor Fibrosis in Pancreatic Ductal Adenocarcinoma by 2-D Shear Wave Elastography: A Pilot Study. Co-author DOI 10.1016/j.ultrasmedbio.2023.06.003↗
- The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. Co-author DOI 10.1016/j.bbcan.2022.188733↗
- Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. Co-author DOI 10.1111/imm.13496↗
- Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.783617↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dong Tang · 4 shared papers, 2021–2023 · strength 0.91
- Paper The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. DOI 10.1016/j.bbcan.2022.188733↗
- Paper Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. DOI 10.1016/j.canlet.2022.216031↗
- Paper Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. DOI 10.1111/imm.13496↗
- Daorong Wang · 3 shared papers, 2021–2023 · strength 0.58
- Paper Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. DOI 10.1016/j.canlet.2022.216031↗
- Paper Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. DOI 10.1111/imm.13496↗
- Paper Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. DOI 10.3389/fcell.2021.783617↗
- Huan Zhang · 2 shared papers, 2021–2022 · strength 0.36
- Paper Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. DOI 10.1111/imm.13496↗
- Paper Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. DOI 10.3389/fcell.2021.783617↗
- Zhengting Jiang · 1 shared paper, 2023 · strength 0.22
- Gengyu Sha · 1 shared paper, 2023 · strength 0.22
- Wenjie Zhang · 1 shared paper, 2023 · strength 0.22
- Lin Shi · 1 shared paper, 2022 · strength 0.20
- Kunlong Duan · 1 shared paper, 2023 · strength 0.19
- Ming Yu · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.